MAY 25, 2016 08:00 AM PDT

Antibodies, Proteins and Peptides - Agilent's Approach to Make Complex Separations Simpler With More Resolution and Speed

SPONSORED BY: Agilent Genomics, Agilent Genomics
C.E. CREDITS: P.A.C.E. CE
Speakers
  • Application Scientist, Agilent Technologies
    Biography
      Dr. Suresh Babu C.V. completed his PhD in Biomolecular Science from Korea Institute of science and Technology, South Korea and did his Postdoctoral fellow at School of Medicine, University of Cincinnati, USA. He has presented various papers in international and national conferences, and has published more than 25 papers in reputed peer reviewed journals. He has an extensive experience in bioanalytical method development, validation and in interpretation of chromatogram, electropherogram and mass spectral data for biomolecule analysis. Currently he is working as Application Scientist at Agilent Technologies for past 7 years. His areas of interest in Biopharma include- LC, LC/MS, CE, CE-MS, electrophoresis, and mass spectrometry.
    • BioColumns Product Support & Applications Scientist, Agilent Technologies
      Biography
        Anne's work in analytical chemistry began at Saint Louis University where she received bachelors degrees in Chemistry and French. She then began her career in mass spectrometry at the University of Arizona where she received her Ph.D. under Dr. Vicki Wysocki, studying mass spectrometry and ion mobility as tools for structural determination of non-covalent protein assemblies. She joined Agilent in 2012, working as an application scientist on LC/QTOF and LC/IM/QTOF instrumentation specializing in metabolomics and lipidomics applications. In 2016 she moved into Agilent's bio-columns group, providing customer support for biological chromatography applications.

      Abstract:
      A quick look at the most recent new drug filings reveals how much interest there is in biologically derived molecules as therapeutic agents. The majority of the filings are for New Biological Entities rather than New Chemical Entities with the largest NBE group being Antibodies. As we move in this direction more and more data about the make up of these molecules, their degradation products, and improperly made versions are required. The need for this information about these complex systems makes efficient chromatographic separations very important to speeding up the development, quality control, and process monitoring of NBEs. 

      This presentation will look at new separation products designed to improve resolution and reproducibility in reverse phase separations. We will explore options for intact as well as reduced and digested proteins.

      For Research Use Only. Not for use in diagnostic procedures.

      Show Resources
      You May Also Like
      MAY 24, 2018 09:30 AM PDT
      C.E. CREDITS
      MAY 24, 2018 09:30 AM PDT
      DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
      MAY 03, 2018 11:00 AM PDT
      MAY 03, 2018 11:00 AM PDT
      DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
      AUG 15, 2018 08:00 AM PDT
      C.E. CREDITS
      AUG 15, 2018 08:00 AM PDT
      DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
      MAY 22, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 22, 2018 08:00 AM PDT
      DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
      JUN 26, 2018 06:00 AM PDT
      C.E. CREDITS
      JUN 26, 2018 06:00 AM PDT
      Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
      APR 27, 2018 10:00 AM PDT
      C.E. CREDITS
      APR 27, 2018 10:00 AM PDT
      DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
      Loading Comments...